These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2138176)

  • 21. Topical zinc therapy for acne vulgaris.
    Cochran RJ; Tucker SB; Flannigan SA
    Int J Dermatol; 1985 Apr; 24(3):188-90. PubMed ID: 3158620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new salt of erythromycin (A-137 or erythromycin lauryl sulfate) in the topical treatment of acne].
    Pérez López M; Moragas Viñas JM
    Med Cutan Ibero Lat Am; 1982; 10(3):151-8. PubMed ID: 6218350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythromycin 2 percent gel in the treatment of acne vulgaris.
    Pochi PE; Bagatell FK; Ellis CN; Stoughton RB; Whitmore CG; Saatjian GD; Sefton J
    Cutis; 1988 Feb; 41(2):132-6. PubMed ID: 2964344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical erythromycin v clindamycin therapy for acne. A multicenter, double-blind comparison.
    Shahlita AR; Smith EB; Bauer E
    Arch Dermatol; 1984 Mar; 120(3):351-5. PubMed ID: 6230999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc.
    Bojar RA; Eady EA; Jones CE; Cunliffe WJ; Holland KT
    Br J Dermatol; 1994 Mar; 130(3):329-36. PubMed ID: 8148274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topically applied erythromycin in inflammatory acne vulgaris.
    Bernstein JE; Shalita AR
    J Am Acad Dermatol; 1980 Apr; 2(4):318-21. PubMed ID: 6444958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Double-blind group comparison of topical meclocycline, erythromycin and placebo in the treatment of papulo-pustulosa acne].
    Rozman TA; Klövekorn G; Kompa H
    Z Hautkr; 1984 Dec; 59(23):1623-34. PubMed ID: 6240840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
    Thomas DR; Raimer S; Smith EB
    Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical erythromycin solution in acne. Results of a multiclinic trial.
    Dobson RL; Belknap BS
    J Am Acad Dermatol; 1980 Nov; 3(5):478-82. PubMed ID: 6452463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical erythromycin and zinc for acne.
    Papa CM
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):318-9. PubMed ID: 1826114
    [No Abstract]   [Full Text] [Related]  

  • 31. Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris.
    Burke B; Eady EA; Cunliffe WJ
    Br J Dermatol; 1983 Feb; 108(2):199-204. PubMed ID: 6218815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris.
    Glass D; Boorman GC; Stables GI; Cunliffe WJ; Goode K
    Dermatology; 1999; 199(3):242-7. PubMed ID: 10592405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle.
    Mills O; Thornsberry C; Cardin CW; Smiles KA; Leyden JJ
    Acta Derm Venereol; 2002; 82(4):260-5. PubMed ID: 12361129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind controlled evaluation of the sebosuppressive activity of topical erythromycin-zinc complex.
    Piérard-Franchimont C; Goffin V; Visser JN; Jacoby H; Piérard GE
    Eur J Clin Pharmacol; 1995; 49(1-2):57-60. PubMed ID: 8751022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a therapeutic strategy for the treatment of acne vulgaris with conventional therapy.
    Greenwood R; Burke B; Cunliffe WJ
    Br J Dermatol; 1986 Mar; 114(3):353-8. PubMed ID: 2937441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of systemic erythromycin stearate on the inflammatory lesions and skin surface fatty acids in acne vulgaris.
    Bleeker J; Hellgren L; Vincent J
    Dermatologica; 1981; 162(5):342-9. PubMed ID: 6454598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharma Clinics. Drug of the month. Benzamycin, an up-date on topical treatment of acne].
    Piérard GE
    Rev Med Liege; 1997 Feb; 52(2):120-2. PubMed ID: 9173479
    [No Abstract]   [Full Text] [Related]  

  • 39. Topical clindamycin therapy for acne vulgaris. A cooperative clinical study.
    Becker LE; Bergstresser PR; Whiting DA; Clendenning WE; Dobson RL; Jordan WP; Abell E; LeZotte LA; Pochi PE; Shupack JL; Sigafoes RB; Stoughton RB; Voorhees JJ
    Arch Dermatol; 1981 Aug; 117(8):482-5. PubMed ID: 6455095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria.
    Eady EA; Bojar RA; Jones CE; Cove JH; Holland KT; Cunliffe WJ
    Br J Dermatol; 1996 Jan; 134(1):107-13. PubMed ID: 8745894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.